Skip to main content
Premium Trial:

Request an Annual Quote

'Course Correction to Compete'

FierceBiotech's Ryan McBride and John Carroll received more than 130 nominations for their 2011 Women in Biotech feature. "True to our mission of providing readers the top news in biotech, many of the honorees here are women who drove some of the big stories we covered this year," they write. These women are "rallying scientists at young startups, gearing up for important late-stage trials or leading research of serious health concerns such as HIV," among other endeavors, McBride and Carroll add. The honorees include the Fred Hutchinson Cancer Research Center's Julie Overbaugh, lauded for her work on the immunological factors that could prevent HIV infections.

Eleven Biotherapeutics' Abbie Celniker tells FierceBiotech that "the potential interesting little extra that you get from speaking to some of the women in biotech is we've probably been challenged with thinking a little bit more about how to cultivate our careers. … As a result, we can be a tiny bit more self-reflective because we've had to do lots of course correction to make sure we could compete in the days when it was more predominately male."

Full profiles for each of the 10 women honored appear here.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.